BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15961397)

  • 1. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Abid MR; Yano K; Guo S; Patel VI; Shrikhande G; Spokes KC; Ferran C; Aird WC
    J Biol Chem; 2005 Aug; 280(33):29864-73. PubMed ID: 15961397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated forkhead transcription factor inhibits neointimal hyperplasia after angioplasty through induction of p27.
    Park KW; Kim DH; You HJ; Sir JJ; Jeon SI; Youn SW; Yang HM; Skurk C; Park YB; Walsh K; Kim HS
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):742-7. PubMed ID: 15662024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Lee HY; Chung JW; Youn SW; Kim JY; Park KW; Koo BK; Oh BH; Park YB; Chaqour B; Walsh K; Kim HS
    Circ Res; 2007 Feb; 100(3):372-80. PubMed ID: 17234971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells.
    Sakakibara K; Kubota K; Worku B; Ryer EJ; Miller JP; Koff A; Kent KC; Liu B
    J Biol Chem; 2005 Jul; 280(27):25470-7. PubMed ID: 15894805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Liu X; Cheng Y; Zhang S; Lin Y; Yang J; Zhang C
    Circ Res; 2009 Feb; 104(4):476-87. PubMed ID: 19150885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
    Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1.
    Yu HZ; Xie LD; Zhu PL; Xu CS; Wang HJ
    Mol Cell Biochem; 2012 Jan; 360(1-2):363-71. PubMed ID: 21959973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGF-BB-mediated activation of CREB in vascular smooth muscle cells alters cell cycling via Rb, FoxO1 and p27
    Perrault R; Molnar P; Poole J; Zahradka P
    Exp Cell Res; 2021 Jul; 404(1):112612. PubMed ID: 33895117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
    Kim TJ; Yun YP
    Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important.
    Vantler M; Caglayan E; Zimmermann WH; Bäumer AT; Rosenkranz S
    J Biol Chem; 2005 Apr; 280(14):14168-76. PubMed ID: 15640155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries.
    Tang Z; Wang Y; Fan Y; Zhu Y; Chien S; Wang N
    Circulation; 2008 Aug; 118(7):764-72. PubMed ID: 18663086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
    Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
    Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.
    Servant MJ; Coulombe P; Turgeon B; Meloche S
    J Cell Biol; 2000 Feb; 148(3):543-56. PubMed ID: 10662779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
    Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
    Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells.
    Komatsu N; Watanabe T; Uchida M; Mori M; Kirito K; Kikuchi S; Liu Q; Tauchi T; Miyazawa K; Endo H; Nagai T; Ozawa K
    J Biol Chem; 2003 Feb; 278(8):6411-9. PubMed ID: 12456669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons.
    Zheng WH; Kar S; Quirion R
    Mol Pharmacol; 2002 Aug; 62(2):225-33. PubMed ID: 12130673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.